AGIO
Agios Pharmaceuticals Inc

2,877
Mkt Cap
$2.06B
Volume
850,263.00
52W High
$57.33
52W Low
$22.24
PE Ratio
-3.99
AGIO Fundamentals
Price
$28.00
Prev Close
$27.42
Open
$27.56
50D MA
$38.22
Beta
1.17
Avg. Volume
2.4M
EPS (Annual)
$11.64
P/B
1.26
Rev/Employee
$74,790.98
Loading...
Loading...
News
all
press releases
Prudential Financial Inc. Lowers Holdings in Agios Pharmaceuticals, Inc. $AGIO
Prudential Financial Inc. reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 22.5% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Envestnet Asset Management Inc. Reduces Holdings in Agios Pharmaceuticals, Inc. $AGIO
Envestnet Asset Management Inc. lowered its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 55.2% in the second quarter, according to its most recent filing with the...
MarketBeat·8d ago
News Placeholder
FY2026 EPS Estimates for AGIO Increased by Cantor Fitzgerald
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Analysts at Cantor Fitzgerald increased their FY2026 earnings per share estimates for Agios Pharmaceuticals in a research note issued on...
MarketBeat·9d ago
News Placeholder
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the...
MarketBeat·10d ago
News Placeholder
What is HC Wainwright's Estimate for AGIO FY2025 Earnings?
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities research analysts at HC Wainwright raised their FY2025 EPS estimates for Agios Pharmaceuticals in a research note issued on...
MarketBeat·13d ago
News Placeholder
Agios Pharmaceuticals, Inc. $AGIO Shares Acquired by CenterBook Partners LP
CenterBook Partners LP increased its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 124.0% during the 2nd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·14d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Given New $20.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. dropped their price objective on shares of Agios Pharmaceuticals from $37.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday...
MarketBeat·14d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Cut to Sell at Wall Street Zen
Wall Street Zen cut Agios Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·15d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Sees Strong Trading Volume After Analyst Upgrade
Agios Pharmaceuticals (NASDAQ:AGIO) Sees Unusually-High Trading Volume After Analyst Upgrade...
MarketBeat·16d ago
News Placeholder
HC Wainwright Lowers Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $48.00
HC Wainwright lowered their price objective on Agios Pharmaceuticals from $56.00 to $48.00 and set a "buy" rating for the company in a research report on Thursday...
MarketBeat·16d ago

Latest AGIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.